The role of natriuretic peptide administration in cardiovascular surgery-associated renal dysfunction: a systematic review and meta-analysis of randomized controlled trials.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Journal of Cardiothoracic and Vascular Anesthesia

• Publication date

  2009-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1053/j.jvca.2008.11.007PMID 19167908
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Analysing and Presenting Results

  2010cited by this paper
• Publication Committee for the VMAC Investigators Randomized Controlled Trial Decompensated Congestive Heart Failure: A Intravenous Nesiritide vs Nitroglycerin for Treatment of

  2009cited by this paper
• The Pathophysiology of Cardiac Surgery-Associated Acute Kidney Injury (CSA-AKI)

  2008cited by this paper
• Fenoldopam reduces the incidence of renal replacement therapy after cardiac surgery.

  2008cited by this paper
• Human atrial natriuretic peptide prevents the increase in pulmonary artery pressure associated with aortic unclamping during abdominal aortic aneurysmectomy.

  2008cited by this paper
• Brain natriuretic peptide is a good predictor for outcome in cardiac surgery

  2008cited by this paper
• A meta‐analysis of the utility of pre‐operative brain natriuretic peptide in predicting early and intermediate‐term mortality and major adverse cardiac events in vascular surgical patients

  2008cited by this paper
• Biomarkers for the diagnosis and risk stratification of acute kidney injury: a systematic review.

  2008cited by this paper
• Fenoldopam reduces the need for renal replacement therapy and in-hospital death in cardiovascular surgery: a meta-analysis.

  2008cited by this paper
• Effects of human atrial natriuretic peptide on renal function in patients undergoing abdominal aortic aneurysm repair*

  2008cited by this paper
• Beneficial impact of fenoldopam in critically ill patients with or at risk for acute renal failure: a meta-analysis of randomized clinical trials.

  2007cited by this paper
• Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury

  2007cited by this paper
• Remote Ischemic Preconditioning Reduces Myocardial and Renal Injury After Elective Abdominal Aortic Aneurysm Repair: A Randomized Controlled Trial

  2007cited by this paper
• Low Dose Nesiritide and the Preservation of Renal Function in Patients With Renal Dysfunction Undergoing Cardiopulmonary-Bypass Surgery: A Double-Blind Placebo-Controlled Pilot Study

  2007cited by this paper
• Effects of perioperative nesiritide in patients with left ventricular dysfunction undergoing cardiac surgery:the NAPA Trial.

  2007cited by this paper
• Efficacy of continuous low-dose hANP administration in patients undergoing emergent coronary artery bypass grafting for acute coronary syndrome.

  2007cited by this paper
• Perioperative Nesiritide Versus Milrinone in High-Risk Coronary Artery Bypass Graft Patients

  2007cited by this paper
• Efficacy of Continuous Low-Dose Human Atrial Natriuretic Peptide Given from the Beginning of Cardiopulmonary Bypass for Thoracic Aortic Surgery

  2006cited by this paper
• Nonhypotensive low-dose nesiritide has differential renal effects compared with standard-dose nesiritide in patients with acute decompensated heart failure and renal dysfunction.

  2006cited by this paper
• Efficacy of Low-Dose Continuous Infusion of α-Human Atrial Natriuretic Peptide (hANP) During Cardiac Surgery

  2006cited by this paper
• Efficacy of low-dose continuous infusion of alpha-human atrial natriuretic peptide (hANP) during cardiac surgery: possibility of postoperative left ventricular remodeling effect.

  2006cited by this paper
• Studying the prevention of acute kidney injury: lessons from an 18th-century mathematician.

  2006cited by this paper
• Equimolar doses of atrial and brain natriuretic peptides and urodilatin have differential renal actions in overt experimental heart failure.

  2005cited by this paper
• Interventions for protecting renal function in the perioperative period.

  2005cited by this paper
• Acute kidney injury associated with cardiac surgery.

  2005cited by this paper
• Isoflurane Protects Renal Function Against Ischemia and Reperfusion Through Inhibition of Protein Kinases, JNK and ERK

  2005cited by this paper
• Outcomes in patients with normal serum creatinine and with artificial renal support for acute renal failure developing after coronary artery bypass grafting.

  2004cited by this paper
• Minimal changes of serum creatinine predict prognosis in patients after cardiothoracic surgery: a prospective cohort study.

  2004cited by this paper
• Renal Insufficiency After Cardiac Surgery

  2004cited by this paper
• Prevention of perioperative acute renal failure: what works?

  2004cited by this paper
• Recombinant human atrial natriuretic peptide in ischemic acute renal failure: A randomized placebo-controlled trial*

  2004cited by this paper
• Natriuretic peptides and acute renal failure.

  2003cited by this paper
• Measuring inconsistency in meta-analyses

  2003cited by this paper
• Synthetic Human &agr;-Atrial Natriuretic Peptide Improves the Management of Postoperative Hypertension and Renal Dysfunction after the Repair of Abdominal Aortic Aneurysm

  2003cited by this paper
• Renal dysfunction and serious infections after open-heart surgery.

  2003cited by this paper
• Synthetic human alpha-atrial natriuretic peptide improves the management of postoperative hypertension and renal dysfunction after the repair of abdominal aortic aneurysm.

  2003cited by this paper
• Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure: A randomized controlled trial

  2002cited by this paper
• Open infrarenal abdominal aortic aneurysm repair: the Cleveland Clinic experience from 1989 to 1998.

  2002cited by this paper
• Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure: a randomized controlled trial.

  2002cited by this paper
• Aortic clamping during elective operations for infrarenal disease: The influence of clamping time on renal function.

  2002cited by this paper
• Intravenous atrial natriuretic peptide prevents left ventricular remodeling in patients with first anterior acute myocardial infarction.

  2001cited by this paper
• Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure. Nesiritide Study Group.

  2000cited by this paper
• Atrial natriuretic factor in oliguric acute renal failure. Anaritide Acute Renal Failure Study Group.

  2000cited by this paper
• Low-dose continuous infusion of human atrial natriuretic peptide during and after cardiac surgery.

  2000cited by this paper
• Effects of intraoperative administration of atrial natriuretic peptide.

  2000cited by this paper
• Alpha-human atrial natriuretic peptide, carperitide, reduces infarct size but not arrhythmias after coronary occlusion/reperfusion in dogs.

  2000cited by this paper
• Practical implications of current natriuretic peptide research

  2000cited by this paper
• Atrial natriuretic factor in oliguric acute renal failure

  2000cited by this paper
• Effects of natriuretic peptides on load and myocardial function in normal and heart failure dogs.

  2000cited by this paper
• Sustained hemodynamic effects of an infusion of nesiritide (human b-type natriuretic peptide) in heart failure: a randomized, double-blind, placebo-controlled clinical trial. Natrecor Study Group.

  1999cited by this paper
• Improving the Quality of Reports of Meta-Analyses of Randomised Controlled Trials: The QUOROM Statement

  1999cited by this paper
• Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses.

  1999cited by this paper
• Acute renal failure following cardiac surgery.

  1999cited by this paper
• Renal Dysfunction after Myocardial Revascularization: Risk Factors, Adverse Outcomes, and Hospital Resource Utilization

  1998cited by this paper
• Natriuretic peptides.

  1998cited by this paper
• Independent association between acute renal failure and mortality following cardiac surgery.

  1998cited by this paper
• URODILATIN (INN: ULARITIDE) AS A NEW DRUG FOR THE THERAPY OF ACUTE RENAL FAILURE FOLLOWING CARDIAC SURGERY

  1997cited by this paper
• Anaritide in acute tubular necrosis. Auriculin Anaritide Acute Renal Failure Study Group.

  1997cited by this paper
• Anaritide in Acute Tubular Necrosis

  1997cited by this paper
• Effects of human atrial natriuretic peptide in patients after coronary artery bypass surgery.

  1996cited by this paper
• Assessing the quality of reports of randomized clinical trials: is blinding necessary?

  1996cited by this paper
• Acute renal failure following cardiac surgery is reverted by administration of Urodilatin (INN: Ularitide).

  1996cited by this paper
• The effect of acute renal failure on mortality. A cohort analysis.

  1996cited by this paper
• Severe hypotension and bradycardia after continuous intravenous infusion of urodilatin (ANP 95–126) in a patient with congestive heart failure

  1995cited by this paper
• Significance of prophylactic urodilatin (INN: ularitide) infusion for the prevention of acute renal failure in patients after heart transplantation.

  1995cited by this paper
• Fortnightly Review: Ten years of natriuretic peptide research: a new dawn for their diagnostic and therapeutic use?

  1994cited by this paper
• Relationship between renal perfusion pressure and blood flow in different regions of the kidney.

  1993cited by this paper
• Atrial natriuretic factor and endothelin interactions in control of vascular tone.

  1990cited by this paper
• Urodilatin (CDD/ANP‐95‐126) is not biologically inactivated by a peptidase from dog kidney cortex membranes in contrast to atrial natriuretic peptide/cardiodilatin (α‐hANP/CDD‐99‐126)

  1988cited by this paper
• Atrial natriuretic peptide inhibits angiotensin-stimulated proximal tubular sodium and water reabsorption

  1987cited by this paper
• Atrial natriuretic peptide causes pre-glomerular vasodilatation and post-glomerular vasoconstriction in rat kidney

  1986cited by this paper
• Atrial natriuretic factor inhibits sodium transport in medullary collecting duct.

  1986cited by this paper
• Effect of synthetic ANP on renal and loop of Henle functions in the young rat.

  1986cited by this paper
• Inhibition of vasopressin action by atrial natriuretic factor.

  1986cited by this paper

• [Therapeutics for acute tubular necrosis in 2020].

  2021cites this paper
• Histopathological assessment of nano n-acetyl cysteine effect on postoperative adhesion in rats

  2021cites this paper
• Acute kidney injury.

  2021cites this paper
• Perioperative Care of the Orthopedic Patient with Renal Disease

  2020cites this paper
• Natriuretic peptides in acute kidney injury - A sojourn on parallel tracks?

  2019cites this paper
• Acute Kidney Injury Post Cardiopulmonary Bypass Surgery

  2018cites this paper
• Prevention and conservative management of acute kidney injury.

  2016cites this paper
• Brain natriuretic peptide for prevention of contrast-inducednephropathy: a meta-analysis of randomized controlled trials

  2016cites this paper
• Acute Kidney Injury in Cardiac Surgery and Cardiac Intensive Care

  2015cites this paper
• Cardiac surgery-associated acute kidney injury.

  2014cites this paper
• ACCF/AHA Practice Guideline

  2013cites this paper
• Cardiac surgery-associated acute kidney injury

  2013cites this paper
• Natriuretic Peptides in the Management of Solid Organ Transplantation Associated Acute Kidney Injury: A Systematic Review and Meta-Analysis

  2013cites this paper
• Peri-operative renal protective strategies in cardiac surgery

  2013cites this paper
• Association Task Force on Practice Guidelines Summary : A Report of the American College of Cardiology Foundation/American Heart 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery: Executive

  2012cites this paper
• Acute kidney injury

  2012cites this paper
• Randomized evidence for reduction of perioperative mortality.

  2012cites this paper
• 2011 ACCF/AHA guideline for coronary artery bypass graft surgery: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.

  2012cites this paper
• Systolic Heart Failure and Anesthetic Considerations

  2012cites this paper
• Foundation/American Heart Association Task Force on Practice Guidelines Executive Summary : A Report of the American College of Cardiology 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery:

  2012cites this paper
• Fenoldopam and acute renal failure in cardiac surgery: a meta-analysis of randomized placebo-controlled trials.

  2012cites this paper
• Special Articles: 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.

  2012cites this paper
• 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Developed in collaboration with the American Association for Thoracic Surgery, Society of Cardiovascular Anesthesi

  2011cites this paper
• Mortality reduction in cardiac anesthesia and intensive care: results of the first International Consensus Conference

  2011cites this paper
• [Acute kidney injury].

  2011cites this paper
• Fracaso renal agudo: manifestaciones clínicas, diagnóstico y tratamiento

  2011cites this paper
• 2011 ACCF/AHA Coronary Artery Bypass Graft Surgery Data Supplements Data Supplement 1. Anesthetic Considerations Author Drug Number of Patients Number of patients with ≥1 SAE (%) RR (95% CI) P-Value Mortality Number of Patients (%) RR

  2011cites this paper
• Comparison of modern open infrarenal and pararenal abdominal aortic aneurysm repair on early outcomes and renal dysfunction at one year.

  2011cites this paper
• 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery: Executive Summary

  2011cites this paper
• ACCF/AHA Practice Guideline 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery: Executive Summary A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines

  2011cites this paper
• Cardiopulmonary Bypass Management and Organ Protection

  2011cites this paper
• Diuretics in acute kidney injury.

  2011cites this paper
• Insuficiencia renal aguda

  2011cites this paper
• 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.

  2011cites this paper
• 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.

  2011cites this paper
• Biomarkers of acute kidney injury in anesthesia, intensive care and major surgery: from the bench to clinical research to clinical practice.

  2010cites this paper
• Brain natriuretic peptide is not reno-protective during renal ischemia-reperfusion injury in the rat.

  2010cites this paper
• Practice Implications of Recent Clinical Trials for the Prevention of Acute Kidney Injury in Cardiovascular Surgery

  2010cites this paper
• Atrial Natriuretic Peptide in Postoperative Acute Renal Failure

  2010cites this paper
• Cardiac surgery and acute kidney injury: emerging concepts

  2009cites this paper
• Akutes Nierenversagen – aktuelle Diagnostik und Therapie

  2009cites this paper